Publicaciones en las que colabora con Maria Fernanda Montenegro Arce (22)

2023

  1. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy

    Cell Death and Disease, Vol. 14, Núm. 11

2021

  1. Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions

    Cancers, Vol. 13, Núm. 1, pp. 1-17

  2. MITF induces escape from innate immunity in melanoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation

    Scientific Reports, Vol. 10, Núm. 1

  2. Rigid Ï -Extended Boron Difluoride Complex with Mega-Stokes Shift for Bioimaging

    Organic Letters, Vol. 22, Núm. 9, pp. 3356-3360

2016

  1. Lebein, A snake venom disintegrin, Induces apoptosis in human melanoma cells

    Toxins, Vol. 8, Núm. 7

  2. Single Heteroatom Fine-Tuning of the Emissive Properties in Organoboron Complexes with 7-(Azaheteroaryl)indole Systems

    Journal of Organic Chemistry, Vol. 81, Núm. 8, pp. 3296-3302

  3. Targeting the epigenetics of the DNA damage response in breast cancer

    Cell Death and Disease, Vol. 7

  4. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis

    Oncogene, Vol. 35, Núm. 47, pp. 6143-6152

2015

  1. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

    BMC Cancer, Vol. 15, Núm. 1

  2. Targeting the epigenetic machinery of cancer cells

    Oncogene, Vol. 34, Núm. 2, pp. 135-143

2014

  1. Effects of a synthetic antitumoral catechin and its tyrosinase-processed product on the structural properties of phosphatidylcholine membranes

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1838, Núm. 5, pp. 1215-1224

  2. Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Cómo convertir la resistencia en el talón de Aquiles del melanoma

    Eubacteria, Núm. 32

  2. Directed Phenotype Switching as an Effective Antimelanoma Strategy

    Cancer Cell, Vol. 24, Núm. 1, pp. 105-119

  3. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma

    Neoplasia (United States), Vol. 15, Núm. 7, pp. 826-839

2012

  1. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance

    Experimental Cell Research, Vol. 318, Núm. 10, pp. 1146-1159

  2. Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation

    PLoS ONE, Vol. 7, Núm. 12

2011

  1. Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma

    ChemMedChem, Vol. 6, Núm. 3, pp. 440-449

2010

  1. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin

    Journal of Cellular Biochemistry, Vol. 110, Núm. 6, pp. 1399-1409